Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001809
Filing Date
2025-08-14
Accepted
2025-08-14 16:01:05
Documents
74
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prof-20250630x10q.htm   iXBRL 10-Q 1470816
2 EX-31.1 prof-20250630xex31d1.htm EX-31.1 10630
3 EX-31.2 prof-20250630xex31d2.htm EX-31.2 10630
4 EX-32 prof-20250630xex32.htm EX-32 6202
  Complete submission text file 0001410578-25-001809.txt   6696486

Data Files

Seq Description Document Type Size
5 EX-101.SCH prof-20250630.xsd EX-101.SCH 42018
6 EX-101.CAL prof-20250630_cal.xml EX-101.CAL 46969
7 EX-101.DEF prof-20250630_def.xml EX-101.DEF 122471
8 EX-101.LAB prof-20250630_lab.xml EX-101.LAB 348225
9 EX-101.PRE prof-20250630_pre.xml EX-101.PRE 280856
77 EXTRACTED XBRL INSTANCE DOCUMENT prof-20250630x10q_htm.xml XML 1305718
Mailing Address 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 L4W 5K5
Business Address 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 L4W 5K5 647-476-1350
Profound Medical Corp. (Filer) CIK: 0001628808 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39032 | Film No.: 251218414
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)